A cohort study of moderate and severe head injury patients found that 67% of the cerebrolysin group achieved good outcomes (GOS 3-5) at 6 months, compared favorably to historical controls matched for age, sex, and initial severity
Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis
PlexusDx works with licensed 503A compounding pharmacies to create personalized formulations of semaglutide injectionstarting at just $189/mo (or $149/mo on the 6-month plan)that can be carefully titrated based on individual tolerance
Fluence plays a critical role on the subsequent distribution of chemotherapy and tumor growth delay in murine mesothelioma xenografts pre-treated by photodynamic therapy
Unraveling the peculiar features of mitochondrial metabolism and dynamics in prostate cancer
Zepbound (tirzepatide) is an FDA-approved injectable medication for weight loss in adults with obesity or overweight with one or more weight-related health conditions